Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bradley Martin

Concepts (325)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
40
2024
557
8.980
 Why?
Chronic Pain
17
2024
166
6.210
 Why?
Opioid-Related Disorders
17
2024
384
4.350
 Why?
Drug Overdose
10
2024
163
3.380
 Why?
Medicaid
23
2021
257
2.910
 Why?
Drug Prescriptions
14
2024
97
2.790
 Why?
Tramadol
3
2024
30
2.530
 Why?
Alcoholism
4
2022
233
2.510
 Why?
Retrospective Studies
38
2024
6134
1.780
 Why?
Antipsychotic Agents
9
2018
232
1.750
 Why?
Adult
55
2024
13324
1.680
 Why?
United States
49
2024
4874
1.680
 Why?
Osteoarthritis, Knee
3
2017
88
1.580
 Why?
Middle Aged
53
2024
12206
1.560
 Why?
Pain
10
2018
381
1.490
 Why?
Humans
95
2024
50208
1.460
 Why?
Health Care Costs
9
2016
170
1.390
 Why?
Medication Adherence
7
2016
130
1.350
 Why?
Viscosupplements
3
2017
14
1.310
 Why?
Anticoagulants
5
2023
253
1.300
 Why?
Adolescent
36
2024
6390
1.300
 Why?
Hyaluronic Acid
3
2017
34
1.290
 Why?
Female
65
2024
26635
1.240
 Why?
Young Adult
26
2024
3981
1.200
 Why?
Male
62
2024
25399
1.200
 Why?
Emergency Service, Hospital
6
2016
484
1.190
 Why?
Schizophrenia
5
2009
256
1.150
 Why?
Aged
37
2024
9405
1.150
 Why?
Analgesics, Non-Narcotic
3
2012
117
1.090
 Why?
Arthroplasty, Replacement, Knee
4
2017
284
1.090
 Why?
Acetaminophen
4
2015
283
1.070
 Why?
Substance-Related Disorders
5
2021
601
1.060
 Why?
Patient Compliance
6
2009
230
1.040
 Why?
Veterans
10
2024
560
1.000
 Why?
Atrial Fibrillation
3
2016
183
0.980
 Why?
Cohort Studies
14
2024
1422
0.970
 Why?
Cross-Over Studies
1
2024
218
0.920
 Why?
Asthma
3
2015
280
0.900
 Why?
Prescription Drugs
6
2014
38
0.890
 Why?
Cost-Benefit Analysis
5
2020
273
0.880
 Why?
Insurance, Health
7
2020
125
0.850
 Why?
Venous Thromboembolism
1
2023
68
0.820
 Why?
Attention Deficit Disorder with Hyperactivity
1
2023
172
0.800
 Why?
Neck Pain
2
2021
10
0.800
 Why?
Back Pain
2
2021
39
0.780
 Why?
Arkansas
14
2024
1985
0.780
 Why?
Drug Utilization
11
2017
77
0.770
 Why?
Hospitalization
6
2016
655
0.770
 Why?
Arthralgia
1
2021
43
0.760
 Why?
Central Nervous System Stimulants
1
2023
213
0.760
 Why?
Professional-Patient Relations
1
2021
47
0.750
 Why?
Insurance, Pharmaceutical Services
2
2019
26
0.740
 Why?
Narcotic Antagonists
2
2024
134
0.710
 Why?
Logistic Models
8
2016
889
0.700
 Why?
Naloxone
1
2020
78
0.680
 Why?
Hydrocodone
3
2024
20
0.660
 Why?
Oxycodone
3
2024
27
0.660
 Why?
Legislation, Drug
1
2019
16
0.650
 Why?
Warfarin
3
2016
86
0.650
 Why?
Contraception
1
2019
29
0.640
 Why?
Decision Support Techniques
2
2016
71
0.640
 Why?
Proton Pump Inhibitors
2
2016
85
0.630
 Why?
Adrenal Cortex Hormones
2
2017
94
0.620
 Why?
Follow-Up Studies
8
2024
2190
0.590
 Why?
Mammography
1
2018
94
0.590
 Why?
Buprenorphine
3
2024
139
0.590
 Why?
Guidelines as Topic
1
2018
111
0.590
 Why?
Practice Guidelines as Topic
3
2017
449
0.580
 Why?
Histamine H2 Antagonists
1
2016
26
0.560
 Why?
Peptic Ulcer
1
2016
14
0.560
 Why?
Mental Disorders
6
2018
395
0.560
 Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.540
 Why?
Education, Pharmacy, Graduate
1
2016
19
0.530
 Why?
Pyridones
1
2016
34
0.530
 Why?
Inappropriate Prescribing
1
2016
18
0.530
 Why?
Risk
4
2020
324
0.520
 Why?
Safety-Based Drug Withdrawals
1
2015
7
0.520
 Why?
Dextropropoxyphene
1
2015
6
0.520
 Why?
Health Expenditures
3
2011
67
0.520
 Why?
For-Profit Insurance Plans
1
2015
2
0.510
 Why?
Brain Ischemia
2
2016
161
0.500
 Why?
Risk Factors
11
2024
3629
0.500
 Why?
Pyrazoles
1
2016
114
0.500
 Why?
Mass Screening
1
2018
346
0.490
 Why?
Quinolines
1
2015
41
0.490
 Why?
Stress, Psychological
1
2016
261
0.490
 Why?
Anticonvulsants
2
2006
122
0.490
 Why?
Acetates
1
2015
49
0.490
 Why?
Opiate Substitution Treatment
3
2024
88
0.490
 Why?
Time Factors
9
2018
2922
0.480
 Why?
Diabetic Neuropathies
1
2015
49
0.480
 Why?
Insurance Claim Reporting
2
2011
11
0.480
 Why?
Critical Illness
1
2016
288
0.470
 Why?
Insurance Claim Review
4
2010
36
0.460
 Why?
Curriculum
2
2018
400
0.460
 Why?
Pain Management
1
2015
162
0.460
 Why?
Palliative Care
1
2016
186
0.450
 Why?
Stroke
2
2016
493
0.450
 Why?
Breast Neoplasms
2
2023
1179
0.440
 Why?
Neoplasms
1
2023
1249
0.430
 Why?
Databases, Factual
8
2022
657
0.430
 Why?
Injections, Intra-Articular
3
2017
33
0.430
 Why?
Computers, Handheld
1
2013
25
0.430
 Why?
Prescription Drug Misuse
3
2024
34
0.430
 Why?
United States Department of Veterans Affairs
5
2024
288
0.420
 Why?
Age Factors
6
2018
1092
0.410
 Why?
Benzodiazepines
3
2024
73
0.400
 Why?
Cross-Sectional Studies
6
2022
1554
0.400
 Why?
Health Personnel
2
2016
254
0.380
 Why?
Community Pharmacy Services
3
2020
67
0.370
 Why?
Kidney Failure, Chronic
2
2022
200
0.350
 Why?
Case-Control Studies
6
2023
1126
0.340
 Why?
Motor Vehicles
1
2009
15
0.330
 Why?
Antidepressive Agents
2
2009
176
0.330
 Why?
Automobile Driving
1
2009
21
0.330
 Why?
Medication Errors
1
2009
26
0.320
 Why?
Pharmacists
3
2019
144
0.320
 Why?
Cost of Illness
3
2013
117
0.310
 Why?
Physicians, Primary Care
2
2018
43
0.310
 Why?
Quality-Adjusted Life Years
2
2020
63
0.310
 Why?
Pain Measurement
6
2021
240
0.300
 Why?
Health Resources
2
2012
75
0.300
 Why?
College Admission Test
2
2018
15
0.290
 Why?
Antimanic Agents
1
2007
14
0.290
 Why?
School Admission Criteria
2
2018
37
0.290
 Why?
Hypoglycemic Agents
1
2008
168
0.280
 Why?
Schools, Pharmacy
2
2018
54
0.280
 Why?
Propensity Score
2
2017
122
0.280
 Why?
Orthopedic Procedures
2
2017
68
0.280
 Why?
Constipation
1
2006
35
0.280
 Why?
Pharmaceutical Services
2
2018
54
0.280
 Why?
Overweight
1
2009
217
0.270
 Why?
Least-Squares Analysis
4
2011
43
0.270
 Why?
Georgia
5
2006
41
0.270
 Why?
Medicare
4
2023
249
0.270
 Why?
Platelet Aggregation Inhibitors
2
2021
174
0.270
 Why?
Knee Joint
2
2017
162
0.260
 Why?
Students, Pharmacy
2
2018
121
0.260
 Why?
Odds Ratio
4
2020
546
0.250
 Why?
Multivariate Analysis
3
2017
581
0.250
 Why?
Controlled Substances
1
2024
7
0.250
 Why?
Risperidone
2
2010
25
0.250
 Why?
Child
9
2019
6851
0.250
 Why?
North Carolina
5
2011
52
0.240
 Why?
Polypharmacy
1
2004
14
0.240
 Why?
Aged, 80 and over
8
2023
3154
0.240
 Why?
Drug Costs
2
2020
39
0.240
 Why?
Renal Dialysis
2
2022
170
0.220
 Why?
Haloperidol
1
2003
47
0.220
 Why?
Hemorrhage
2
2023
197
0.220
 Why?
Direct Service Costs
1
2003
5
0.220
 Why?
Irritable Bowel Syndrome
1
2003
17
0.210
 Why?
Employment
1
2003
90
0.210
 Why?
Prevalence
4
2018
951
0.210
 Why?
Aftercare
1
2023
75
0.210
 Why?
Premedication
1
2002
21
0.210
 Why?
Dose-Response Relationship, Drug
5
2014
1378
0.210
 Why?
Age Distribution
4
2018
168
0.210
 Why?
Diabetes Mellitus, Type 2
1
2008
486
0.210
 Why?
Health Services Needs and Demand
1
2004
158
0.200
 Why?
Neuralgia
1
2023
63
0.200
 Why?
Common Cold
1
2002
6
0.200
 Why?
Bronchitis
1
2002
12
0.200
 Why?
Proportional Hazards Models
4
2017
410
0.200
 Why?
Thromboembolism
1
2002
54
0.200
 Why?
Accidents
1
2021
21
0.200
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
154
0.190
 Why?
Depressive Disorder, Major
2
2020
151
0.190
 Why?
Forecasting
3
2009
150
0.190
 Why?
Mental Health Services
1
2004
199
0.190
 Why?
Ambulatory Care Facilities
1
2002
125
0.190
 Why?
Respiratory Tract Infections
1
2002
76
0.190
 Why?
Patient Discharge
1
2023
319
0.180
 Why?
Interprofessional Relations
2
2018
85
0.180
 Why?
Afghan Campaign 2001-
2
2018
40
0.180
 Why?
Administration, Oral
2
2016
434
0.180
 Why?
Obesity
1
2009
1108
0.180
 Why?
United States Food and Drug Administration
3
2011
91
0.180
 Why?
Administration, Intranasal
1
2020
29
0.180
 Why?
Markov Chains
1
2020
30
0.180
 Why?
Cardiovascular Diseases
2
2018
443
0.180
 Why?
Brain Neoplasms
1
2023
288
0.170
 Why?
Social Media
1
2022
96
0.170
 Why?
Preventive Health Services
1
2020
50
0.170
 Why?
Child, Preschool
5
2011
3883
0.160
 Why?
Insurance Coverage
1
2020
102
0.160
 Why?
Regression Analysis
4
2013
395
0.160
 Why?
Sepsis
1
2021
221
0.160
 Why?
Drug Administration Schedule
3
2011
377
0.160
 Why?
Delivery of Health Care
1
2021
310
0.160
 Why?
Health Care Surveys
2
2011
172
0.160
 Why?
Public Health Surveillance
1
2018
13
0.160
 Why?
Thiazoles
2
2016
53
0.150
 Why?
Sleep Deprivation
1
2018
16
0.150
 Why?
Papillomavirus Vaccines
1
2019
61
0.150
 Why?
Pharmacies
1
2019
61
0.150
 Why?
Advisory Committees
1
2018
61
0.150
 Why?
Physicians
1
2021
230
0.150
 Why?
Chronic Disease
5
2011
571
0.150
 Why?
Metabolic Diseases
1
2018
39
0.150
 Why?
Lung Neoplasms
1
2023
605
0.150
 Why?
Veterans Health
2
2014
62
0.150
 Why?
Molecular Weight
1
2017
85
0.150
 Why?
Acute Pain
1
2017
9
0.150
 Why?
Papillomavirus Infections
1
2019
155
0.140
 Why?
Treatment Outcome
7
2010
5155
0.140
 Why?
Educational Measurement
1
2018
207
0.140
 Why?
Monte Carlo Method
1
2016
85
0.140
 Why?
Early Detection of Cancer
1
2018
167
0.140
 Why?
Anti-Bacterial Agents
1
2002
747
0.130
 Why?
Education, Pharmacy
1
2018
143
0.130
 Why?
Health Services Accessibility
1
2020
399
0.130
 Why?
Postoperative Complications
1
2002
996
0.130
 Why?
Geriatrics
1
2016
46
0.130
 Why?
Sulfides
1
2015
28
0.120
 Why?
Models, Theoretical
1
2016
174
0.120
 Why?
Cyclopropanes
1
2015
23
0.120
 Why?
Pyridines
1
2016
131
0.120
 Why?
Renal Insufficiency, Chronic
1
2018
169
0.120
 Why?
Thrombosis
1
2018
248
0.120
 Why?
Anti-Asthmatic Agents
1
2015
30
0.120
 Why?
Societies, Medical
1
2016
177
0.120
 Why?
Severity of Illness Index
2
2016
951
0.120
 Why?
Self Report
1
2016
199
0.120
 Why?
Long-Term Care
3
2012
52
0.120
 Why?
Health Literacy
1
2016
128
0.120
 Why?
California
2
2004
87
0.110
 Why?
Comorbidity
5
2017
613
0.110
 Why?
Prescriptions
2
2011
10
0.110
 Why?
Risk Assessment
2
2015
1262
0.110
 Why?
Monitoring, Physiologic
1
2013
120
0.110
 Why?
Sensitivity and Specificity
1
2015
863
0.110
 Why?
Guideline Adherence
2
2023
133
0.100
 Why?
Infant
3
2011
3563
0.100
 Why?
Managed Care Programs
1
2012
37
0.100
 Why?
Ticlopidine
1
2012
55
0.100
 Why?
Deductibles and Coinsurance
1
2011
2
0.100
 Why?
Hypertension, Pulmonary
1
2012
121
0.090
 Why?
Body Mass Index
2
2013
656
0.090
 Why?
Health Policy
1
2011
154
0.090
 Why?
Calibration
1
2009
58
0.080
 Why?
International Classification of Diseases
1
2009
64
0.080
 Why?
Clozapine
2
2010
26
0.080
 Why?
Reference Values
1
2009
310
0.080
 Why?
Analysis of Variance
1
2010
564
0.080
 Why?
Treatment Refusal
1
2009
37
0.080
 Why?
Evidence-Based Medicine
1
2010
247
0.080
 Why?
Carbamazepine
1
2007
13
0.070
 Why?
Lithium Compounds
1
2007
11
0.070
 Why?
Mental Health
1
2010
220
0.070
 Why?
Alendronate
1
2007
23
0.070
 Why?
Valproic Acid
1
2007
32
0.070
 Why?
Fractures, Spontaneous
1
2007
16
0.070
 Why?
Chemotherapy, Adjuvant
1
2007
120
0.070
 Why?
Osteoporosis, Postmenopausal
1
2007
29
0.070
 Why?
Affect
1
2007
99
0.070
 Why?
Drug Labeling
1
2006
11
0.070
 Why?
Bone Density Conservation Agents
1
2007
74
0.070
 Why?
Predictive Value of Tests
1
2008
905
0.070
 Why?
Adrenergic beta-Agonists
1
2005
40
0.060
 Why?
Self Disclosure
1
2005
13
0.060
 Why?
Drug Interactions
2
2018
208
0.060
 Why?
Depression
1
2009
570
0.060
 Why?
Eligibility Determination
1
2004
17
0.060
 Why?
Factor Analysis, Statistical
1
2004
74
0.060
 Why?
Urban Population
1
2005
150
0.060
 Why?
Health Surveys
2
2018
232
0.060
 Why?
Prescription Fees
1
2004
14
0.060
 Why?
Length of Stay
1
2007
621
0.060
 Why?
Algorithms
1
2007
618
0.060
 Why?
Drug Therapy, Combination
1
2004
381
0.060
 Why?
MEDLINE
1
2002
8
0.050
 Why?
Prospective Studies
1
2008
2379
0.050
 Why?
Enoxaparin
1
2002
27
0.050
 Why?
Neuropsychological Tests
1
2003
355
0.050
 Why?
Cognition Disorders
1
2003
215
0.050
 Why?
Gastrointestinal Hemorrhage
1
2022
79
0.050
 Why?
Longitudinal Studies
2
2014
695
0.050
 Why?
Data Collection
1
2002
277
0.050
 Why?
Patient Protection and Affordable Care Act
1
2020
50
0.040
 Why?
Needs Assessment
1
2020
133
0.040
 Why?
Quality of Health Care
1
2020
187
0.040
 Why?
Incidence
2
2014
1006
0.040
 Why?
Pharmacoepidemiology
1
2017
8
0.040
 Why?
Pharmacy
1
2018
57
0.040
 Why?
Universities
1
2018
162
0.040
 Why?
Vaccination
1
2019
271
0.040
 Why?
Pilot Projects
1
2019
697
0.030
 Why?
Communication
1
2018
246
0.030
 Why?
Electronic Health Records
1
2018
213
0.030
 Why?
Qualitative Research
1
2018
336
0.030
 Why?
Decision Making
1
2018
267
0.030
 Why?
Reminder Systems
1
2016
29
0.030
 Why?
Medication Therapy Management
1
2016
24
0.030
 Why?
Attitude of Health Personnel
1
2018
351
0.030
 Why?
Ischemic Attack, Transient
1
2013
56
0.030
 Why?
Lipids
1
2013
148
0.030
 Why?
Survival Analysis
1
2014
666
0.030
 Why?
Linear Models
1
2013
278
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2017
365
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.030
 Why?
Diagnostic Tests, Routine
1
2012
29
0.020
 Why?
Cost Control
1
2011
13
0.020
 Why?
Acute Coronary Syndrome
1
2012
78
0.020
 Why?
Blood Pressure
1
2013
524
0.020
 Why?
Blood Glucose
1
2013
435
0.020
 Why?
Dibenzothiazepines
1
2010
10
0.020
 Why?
Adolescent Behavior
1
2011
102
0.020
 Why?
Hypnotics and Sedatives
1
2010
75
0.020
 Why?
Off-Label Use
1
2010
25
0.020
 Why?
Diabetes Mellitus
1
2013
286
0.020
 Why?
Quinolones
1
2010
39
0.020
 Why?
Mood Disorders
1
2009
59
0.020
 Why?
Anxiety Disorders
1
2009
126
0.020
 Why?
Piperazines
1
2010
118
0.020
 Why?
Headache
1
2008
76
0.020
 Why?
Sex Factors
1
2009
697
0.020
 Why?
Confidence Intervals
1
2007
156
0.020
 Why?
Probability
1
2007
164
0.020
 Why?
Drug Utilization Review
1
2005
23
0.020
 Why?
Bone Density
1
2007
379
0.020
 Why?
Drug Monitoring
1
2005
78
0.020
 Why?
Registries
1
2007
522
0.010
 Why?
Quality of Life
1
2008
839
0.010
 Why?
Reproducibility of Results
1
2005
1185
0.010
 Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (325) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department